medRxiv PreprintsInternational20 November 2026
Circulating miRNA profiling identifies hsa-miR-23a-3p and a three-miRNA signature associated with serous ovarian cancer
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
High-grade serous ovarian carcinoma (HGSOC) is the most lethal subtype of epithelial ovarian cancer, highlighting the need for minimally invasive biomarkers that support disease detection and molecular characterization. Circulating microRNAs (miRNAs) have emerged as promising candidates, although their clinical applicability remains limited by methodological variability and insufficient validation. Plasma samples from 100 individuals (50 patients with ovarian cancer and 50 cancer-free controls) were initially collected from four biobanks. Following quality control, 94 samples (47 patients and
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.